Tekla Capital Management’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $500K | Hold |
200,000
| – | – | 0.02% | 142 |
|
|
2023
Q1 | $420K | Hold |
200,000
| – | – | 0.02% | 156 |
|
|
2022
Q4 | $326K | Hold |
200,000
| – | – | 0.01% | 154 |
|
|
2022
Q3 | $610K | Hold |
200,000
| – | – | 0.03% | 142 |
|
|
2022
Q2 | $629K | Hold |
200,000
| – | – | 0.02% | 143 |
|
|
2022
Q1 | $560K | Hold |
200,000
| – | – | 0.02% | 159 |
|
|
2021
Q4 | $900K | Hold |
200,000
| – | – | 0.03% | 148 |
|
|
2021
Q3 | $1.67M | Buy |
+200,000
| New | +$1.67M | 0.05% | 140 |
|